NCT00489528View on ClinicalTrials.gov

Growth Hormone in the Treatment of HIV-Associated Wasting

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1997

Study Completion Date

March 31, 2002

Conditions
HIV InfectionsHIV Wasting Syndrome
Interventions
DRUG

Somatropin; Recombinant human growth hormone (r hGH)

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00489528 - Growth Hormone in the Treatment of HIV-Associated Wasting | Biotech Hunter | Biotech Hunter